Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/23338
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.date.accessioned2021-12-16T12:01:04Z-
dc.date.available2021-12-16T12:01:04Z-
dc.date.issued2011-08-
dc.identifier.citationGasanov, F. vd. (2011). "The effects of tadalafil on renal ischemia reperfusion injury: An experimental study". Bosnian Journal of Basic Medical Sciences, 11(3), 158-162.en_US
dc.identifier.issn1512-8601-
dc.identifier.urihttps://doi.org/10.17305/bjbms.2011.2567-
dc.identifier.urihttps://www.bjbms.org/ojs/index.php/bjbms/article/view/2567-
dc.identifier.urihttp://hdl.handle.net/11452/23338-
dc.description.abstractMany pharmacological agents were investigated for the prevention of renal ischemic reperfusion (I/R) injury as well as the phosphodiesterase (PDE) inhibitors. The aim of the study was to examine the possible renoprotective effect of a member in this family, tadalafil (Td) on I/R injury. Thirty-six Sprague Dawley rats were allocated to six groups as; control, sham, ischemia (I), ischemia/reperfusion (I/R), Td pretreatment ischemia (Td/I) and Td pretreatment ischemia/reperfusion (Td/IR) groups. Right nephrectomy was performed in all groups. Td was dissolved in saline solution and given as a single dose (1mg/kg) through an orogastrictube 60 min before the operation in the Td pretreatment groups. In ischemia group the left renal pedicle was occluded for 45 minutes and after than underwent left nephrectomy. In I/R group left renal pedicle was occluded for 45 minutes, reperfused for I hour and after then underwent nephrectomy. The left kidneys were evaluated after standard laboratory procedures with regard to tubular morphology, and leukocyte infiltration. The data were analyzed by using Kruskal Wallis test to determine differences among the groups. A p value of < 0.05 was considered significant. Renal tubular damage was significant increased in the ischemia and I/R group (Groups III and IV) when compared to those in the sham group (Group II), (p = 0.004, 0.004, respectively). Tubular damage, in the Td pretreatment ischemia (Td/I) (Group V) and Td pretreatment ischemia/reperfusion (Td/IR) (Group VI) were less than that in the ischemia group (Group III) (p=0.0010, p=0.025, respectively). Td administration prior to the renal I/R injury attenuated these morphological disarrangements, which were observed in renal I/R. Tubular necrosis, which may be considered as an important issue of the developing renal injury, was also completely prevented with Td administration.en_US
dc.language.isoenen_US
dc.publisherAssoc Basic Meical Sci Federarion Bosbia & Herzegovina Saraen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectResearch & experimental medicineen_US
dc.subjectKidneyen_US
dc.subjectTadalafilen_US
dc.subjectRaten_US
dc.subjectIschemia/reperfusion injuryen_US
dc.subjectCyclic-gmpen_US
dc.subjectRatsen_US
dc.subjectInhibitionen_US
dc.subjectFailureen_US
dc.subjectKidneyen_US
dc.subjectPde5en_US
dc.subjectNeutrophilsen_US
dc.subjectDysfunctionen_US
dc.subjectOlprinoneen_US
dc.titleThe effects of tadalafil on renal ischemia reperfusion injury: An experimental studyen_US
dc.typeArticleen_US
dc.identifier.wos000295237200004tr_TR
dc.identifier.scopus2-s2.0-80052410919tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Üroloji Anabilim Dalı.tr_TR
dc.identifier.startpage158tr_TR
dc.identifier.endpage162tr_TR
dc.identifier.volume11tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalBosnian Journal of Basic Medical Sciencesen_US
dc.contributor.buuauthorGasanov, Feyzullah-
dc.contributor.buuauthorAytaç, Berna-
dc.contributor.buuauthorVuruşkan, Hakan-
dc.contributor.researcheridAAH-9746-2021tr_TR
dc.identifier.pubmed21875417tr_TR
dc.subject.wosMedicine, research & experimentalen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid56629254000tr_TR
dc.contributor.scopusid56527372000tr_TR
dc.contributor.scopusid6507328150tr_TR
dc.subject.scopusPhosphodiesterase V Inhibitor; Tadalafil; Sildenafilen_US
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Dosya Açıklama BoyutBiçim 
Gasanov_vd_2011.pdf183.17 kBAdobe PDFKüçük resim
Göster/Aç


Bu öğe kapsamında lisanslı Creative Commons License Creative Commons